Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Baxter

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Vangard Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for VANGARD, and what generic and branded alternatives to VANGARD drugs are available?

VANGARD has forty-five approved drugs.



Summary for Vangard
US Patents:0
Tradenames:26
Ingredients:25
NDAs:45

Drugs and US Patents for Vangard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vangard MEPROBAMATE meprobamate TABLET;ORAL 088011-001 Jul 14, 1982 DISCN No No   Start Trial   Start Trial
Vangard HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 087610-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Vangard TRIHEXYPHENIDYL HYDROCHLORIDE trihexyphenidyl hydrochloride TABLET;ORAL 088035-001 Jul 30, 1982 DISCN No No   Start Trial   Start Trial
Vangard ERGOLOID MESYLATES ergoloid mesylates TABLET;SUBLINGUAL 088013-001 Sep 20, 1982 DISCN No No   Start Trial   Start Trial
Vangard HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 087712-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
McKesson
Johnson and Johnson
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.